Red yeast rice: a functional food used to reduce hyperlipidemia

References

• Ma, Y.; Wang, W.; Zhang, J., Lu, Y., Wu, W., Yan, H., and Wang, Y.; et al. Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet. PLoS One. 2012, 7(4), e35835. doi:10.1371/journal.pone.0035835.
   PubMed Web of Science ®Google Scholar
• Yanai, H.; Yoshida, H. Secondary Dyslipidemia: Its Treatments and Association with Atherosclerosis. Glob. Health Med. 2021, 3(1), 15–23. doi:10.35772/ghm.2020.01078.
   PubMedGoogle Scholar
• Ito, M. K.; Watts, G. F. Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia. Drugs. 2015, 75(15), 1715–1724. doi:10.1007/s40265-015-0466-y.
   PubMed Web of Science ®Google Scholar
• Catapano, A. L.; Graham, I., and De Backer, G., et al. ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the Special Contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016, 2016(253), 281–344. doi:10.1016/j.atherosclerosis.2016.08.018.
   Web of Science ®Google Scholar
• Nie, Y.; Luo, F.; Deng, W. Dietary Fiber: An Opportunity for a Global Control of Hyperlipidemia. Oxid. Med. Cell Longev. 2021, 2021, 5542342. doi:10.1155/2021/5542342.
   PubMed Web of Science ®Google Scholar
• Dong, Y.; Li, X.; Liu, Y., Gao, J., Tao, J.; et al. The Molecular Targets of Taurine Confer Anti-Hyperlipidemic Effects. Life Sci. 2021, 278, 119579. doi:10.1016/j.lfs.2021.119579.
   PubMed Web of Science ®Google Scholar
• Mollazadeh, H.; Tavana, E.; Fanni, G., Bo, S., Banach, M., Pirro, M., Haehling, S., Jamialahmadi, T., and Sahebkar, A.; et al. Effects of Statins on Mitochondrial Pathways. J. Cachexia Sarcopenia Muscle. 2021, 12(2), 237–251. doi:10.1002/jcsm.12654.
   PubMed Web of Science ®Google Scholar
• Karr, S. Epidemiology and Management of Hyperlipidemia. Am.J Manag. Care. 2017, 23(9 Suppl), S139–S148. 28978219
   PubMed Web of Science ®Google Scholar
• Kozarov, E.; Padro, T.; Badimon, L. View of Statins as Antimicrobials in Cardiovascular Risk Modification. Cardiovasc. Res. 2014, 102(3), 362–374. doi:10.1093/cvr/cvu058.
   PubMed Web of Science ®Google Scholar
• Thompson, P. D.; Panza, G.; Zaleski, A., and Taylor, B.; et al. Statin-Associated Side Effects. J. Am. Coll. Cardiol. 2016, 67(20), 2395–2410. doi:10.1016/j.jacc.2016.02.071.
   PubMed Web of Science ®Google Scholar
• Crisan, E.; Patil, V. K. Neuromuscular Complications of Statin Therapy. Curr. Neurol. Neurosci. Rep. 2020, 20(10), 47. doi:10.1007/s11910-020-01064-0.
   PubMed Web of Science ®Google Scholar
• Gupta, A.; Thompson, D.; Whitehouse, A., Collier, T., Dahlof, B., Poulter, N., Collins, R., and Sever, P.; et al. Adverse Events Associated with Unblinded, but Not with Blinded, Statin Therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): A Randomised Double-Blind Placebo-Controlled Trial and Its Non-Randomised Non-Blind Extension Phase. Lancet (London, England). 2017, 389(10088), 2473–2481. doi:10.1016/S0140-6736(17)31075-9.
   PubMed Web of Science ®Google Scholar
• Howard, J. P.; Wood, F. A., and Finegold, J. A., et al. Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment. J. Am. Coll. Cardiol. 2021, 78(12), 1210–1222. doi:10.1016/j.jacc.2021.07.022.
   PubMed Web of Science ®Google Scholar
• Penson, P. E.; Banach, M. Nocebo/drucebo Effect in Statin-Intolerant Patients: An Attempt at Recommendations. Eur. Heart J. 2021, 42(47), 4787–4788. doi:10.1093/eurheartj/ehab358.
   PubMed Web of Science ®Google Scholar
• Song, J.; Luo, J.; Ma, Z., Sun, Q., Wu, C., and Li, X.; et al. Quality and Authenticity Control of Functional Red Yeast Rice—a Review. Molecules. 2019, 24(10), 1944. doi:10.3390/molecules24101944.
   PubMed Web of Science ®Google Scholar
• Gordon, R. Y.; Becker, D. J. The Role of Red Yeast Rice for the Physician. Curr. Atheroscler. Rep. 2011, 13(1), 73–80. doi:10.1007/s11883-010-0145-0.
   PubMed Web of Science ®Google Scholar
• Ruscica, M.; Penson, P. E.; Ferri, N., et al. Impact of Nutraceuticals on Markers of Systemic Inflammation: Potential Relevance to Cardiovascular Diseases – A Position Paper from the International Lipid Expert Panel (ILEP). Prog. Cardiovasc. Dis. 2021, 67, 40–52. doi:10.1016/j.pcad.2021.06.010.
   PubMed Web of Science ®Google Scholar
• Johnston, T. P.; Korolenko, T. A.; Pirro, M., Sahebkar, A.; et al. Preventing Cardiovascular Heart Disease: Promising Nutraceutical and Non-Nutraceutical Treatments for Cholesterol Management. Pharmacol. Res. 2017, 120, 219–225. doi:10.1016/j.phrs.2017.04.008.
   PubMed Web of Science ®Google Scholar
• Venero, C. V.; Venero, J. V.; Wortham, D. C., and Thompson, P. D.; et al. Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins. Am. J. Cardiol. 2010, 105(5), 664–666. doi:10.1016/j.amjcard.2009.10.045.
   PubMed Web of Science ®Google Scholar
• Banach, M.; Bruckert, E.; Descamps, O. S., et al. The Role of Red Yeast Rice (RYR) Supplementation in Plasma Cholesterol Control: A Review and Expert Opinion. Atheroscler. Suppl. 2019, 39, e1–e8. doi:10.1016/j.atherosclerosissup.2019.08.023.
   PubMed Web of Science ®Google Scholar
• Burke, F. M. Red Yeast Rice for the Treatment of Dyslipidemia. Curr. Atheroscler. Rep. 2015, 17(4), 495. doi:10.1007/s11883-015-0495-8.
   PubMed Web of Science ®Google Scholar
• Wang, T. J.; Lien, A. S.; Chen, J. L., Lin, C.-H., Yang, Y.-S., and Yang, S.-H.; et al. A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus Pilosus) Against Hyperlipidemia. Am. J. Chin. Med. 2019, 47(2), 323–335. doi:10.1142/S0192415X19500150.
   PubMed Web of Science ®Google Scholar
• Chen, C. H.; Yang, J. C.; Uang, Y. S., and Lin, C.-J.; et al. Improved Dissolution Rate and Oral Bioavailability of Lovastatin in Red Yeast Rice Products. Int. J. Pharm. 2013, 444(1–2), 18–24. doi:10.1016/j.ijpharm.2013.01.028.
   PubMedGoogle Scholar
• Chen, C. H.; Uang, Y. S.; Wang, S. T., Yang, J.-C., Lin, C.-J.; et al. Interaction Between Red Yeast Rice and CYP450 Enzymes/p-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. Evid. Based Complement. Alternat. Med. 2012, 2012, 127043. doi:10.1155/2012/127043.
   PubMed Web of Science ®Google Scholar
• Nguyen, T.; Karl, M.; Santini, A. J. F. Red Yeast Rice. Foods. 2017, 6(3), 19. doi:10.3390/foods6030019.
   PubMed Web of Science ®Google Scholar
• Fukami, H.; Higa, Y., and Hisano, T., et al. A Review of Red Yeast Rice, a Traditional Fermented Food in Japan and East Asia: Its Characteristic Ingredients and Application in the Maintenance and Improvement of Health in Lipid Metabolism and the Circulatory System. Molecules. 2021, 26(6), 1619. doi:10.3390/molecules26061619.
   PubMed Web of Science ®Google Scholar
• Patel, S. Functional Food Red Yeast Rice (RYR) for Metabolic Syndrome Amelioration: A Review on Pros and Cons. World J. Microbiol. Biotechnol. 2016, 32(5), 87. doi:10.1007/s11274-016-2035-2.
   PubMed Web of Science ®Google Scholar
• Ma, J.; Li, Y.; Ye, Q., Li, J., Hua, Y., Ju, D., Zhang, D., Cooper, R., and Chang, M.; et al. Constituents of Red Yeast Rice, a Traditional Chinese Food and Medicine. J. Agric. Food Chem. 2000, 48(11), 5220–5225. doi:10.1021/jf000338c.
   PubMed Web of Science ®Google Scholar
• Klingelhöfer, I.; Morlock, G. E. Lovastatin in Lactone and Hydroxy Acid Forms and Citrinin in Red Yeast Rice Powders Analyzed by HPTLC-UV/FLD. Anal. Bioanal. Chem. 2019, 411(25), 6655–6665. doi:10.1007/s00216-019-02039-y.
   PubMed Web of Science ®Google Scholar
• Lin, F. Textual Research on Gutian as Place Where Red Yeast Rice Originated. Chin. Tradit. Herb Drug. 2017, 48(13), 2793–2800. doi:10.7501/j.issn.0253-2670.2017.13.032.
   Google Scholar
• Yang, C. W.; Mousa, S. A. The Effect of Red Yeast Rice (Monascus purpureus) in Dyslipidemia and Other Disorders. Complement Ther. Med. 2012, 20(6), 466–474. doi:10.1016/j.ctim.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Endo, A.; Kuroda, M.; Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J. Antibiot (Tokyo), 1976, 29(12), 1346–1348. doi:10.7164/antibiotics.29.1346.
   PubMed Web of Science ®Google Scholar
• Endo, A. Monacolin K, a New Hypocholesterolemic Agent Produced by a Monascus Species. J. Antibiot. (Tokyo). 1979, 32(8), 852–854. doi:10.7164/antibiotics.32.852.
   PubMed Web of Science ®Google Scholar
• Cicero A. F. G.; Fogacci F.; Banach M. Red Yeast Rice for Hypercholesterolemia. Red Yeast Rice for Hypercholesterolemia. Methodist Debakey Cardiovasc. J. 2019, 15(3), 192–199. doi:10.14797/mdcj-15-3-192.s.
   PubMedGoogle Scholar
• Brown, M. S.; Goldstein, J. L. How LDL Receptors Influence Cholesterol and Atherosclerosis. Sci. Am. 1984, 251(5), 58–66. doi:10.1038/scientificamerican1184-58.
   PubMed Web of Science ®Google Scholar
• Samsudin, N. I.; Abdullah, N. A Preliminary Survey on the Occurrence of Mycotoxigenic Fungi and Mycotoxins Contaminating Red Rice at Consumer Level in Selangor, Malaysia. Mycotoxin Res. 2013, 29(2), 89–96. doi:10.1007/s12550-012-0154-7.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. T.; Wang, Y.; Zhang, X. T., Wu, D.-L., Zhang, X.-Q., and Ye, W.-C.; et al. A New Decalin Derivative from Red Yeast Rice. J. Asian Nat. Prod. Res. 2009, 11(9), 792–795. doi:10.1080/10286020903164269.
   PubMed Web of Science ®Google Scholar
• Huang, X.; Tang, S.; Zheng, L., Teng, Y., Yang, Y., Zhu, J., and Lu, X.; et al. Construction of an Efficient and Robust Aspergillus Terreus Cell Factory for Monacolin J Production. ACS Synth. Biol. 2019, 8(4), 818–825. doi:10.1021/acssynbio.8b00489.
   PubMed Web of Science ®Google Scholar
• Zhang, Z.; Ali, Z.; Khan, S. I., Khan, I. A.; et al. Cytotoxic Monacolins from Red Yeast Rice, a Chinese Medicine and Food. Food Chem. 2016, 202, 262–268. doi:10.1016/j.foodchem.2015.12.039.
   PubMed Web of Science ®Google Scholar
• Endo, A.; Komagata, D.; Shimada, H. Monacolin M, a New Inhibitor of Cholesterol Biosynthesis. J. Antibiot. (Tokyo). 1986, 39(12), 1670–1673. doi:10.7164/antibiotics.39.1670.
   PubMed Web of Science ®Google Scholar
• Sorensen, J. L.; Vederas, J. C. Monacolin N, a Compound Resulting from Derailment of Type I Iterative Polyketide Synthase Function En Route to Lovastatin. Chem. Commun. 2003, 13(13), 1492–1493. doi:10.1039/b304252a.
   Google Scholar
• Liu, M. T.; Wang, A. L.; Sun, Z., Li, J.-J., Wu, X.-L., Liu, Y.-X., and Shang, X.-Y.; et al. Cytotoxic Monacolin Analogs from Monascus Purpureus -Fermented Rice. J. Asian Nat. Prod. Res. 2013, 15(6), 600–609. doi:10.1080/10286020.2013.790379.
   PubMed Web of Science ®Google Scholar
• Zhang, B.; Liu, T. X.; Wang, A. L., Li, J.-J., Wang, X., Luan, N., Ji, L.-L., and Shang, X.-Y.; et al. Four New Monacolin Analogs from Monascus Purpureus -Fermented Rice. J. Asian Nat. Prod. Res. 2018, 20(3), 209–216. doi:10.1080/10286020.2017.1396978.
   PubMed Web of Science ®Google Scholar
• Endo, A.; Hasumi, K.; Nakamura, T., Kunishima, M., and Masuda, M.; et al. Dihydromonacolin L and Monacolin X. New Metabolites Those Inhibit Cholesterol Biosynthesis. J. Antibiot. (Tokyo). 1985, 38(3), 321–327. doi:10.7164/antibiotics.38.321.
   PubMed Web of Science ®Google Scholar
• Zhu, L.; Yau, L. F.; Lu, J. G., Zhu, G.-Y., Wang, J.-R., Han, Q.-B., Hsiao, W.-L., and Jiang, Z.-H.; et al. Cytotoxic Dehydromonacolins from Red Yeast Rice. J. Agric. Food Chem. 2012, 60(4), 934–939. doi:10.1021/jf203579f.
   PubMed Web of Science ®Google Scholar
• Dhale, M. A.; Divakar, S.; Umesh-Kumar, S., and Vijayalakshmi, G.; et al. Characterization of Dehydromonacolin-MV2 from Monascus Purpureus Mutant. J. Appl. Microbiol. 2007, 103(6), 2168–2173. doi:10.1111/j.1365-2672.2007.03457.x.
   PubMed Web of Science ®Google Scholar
• Dhale, M. A.; Divakar, S.; Kumar, S. U.; Vijayalakshmi, G. Isolation and Characterization of Dihydromonacolin-MV from Monascus Purpureus for Antioxidant Properties. Appl. Microbiol. Biotechnol. 2007, 73(5), 1197–1202. doi:10.1007/s00253-006-0578-0.
   PubMed Web of Science ®Google Scholar
• Liu, B. Y.; Xu, F.; Bai, J., Yan, D.-J., Zhang, L., Zhang, D., and Hu, Y.-C.; et al. Six New Monacolin Analogs from Red Yeast Rice. Chin. J. Nat. Med. 2019, 17(5), 394–400. doi:10.1016/S1875-5364(19)30046-9.
   PubMed Web of Science ®Google Scholar
• Peng, Y.; Zhang, X.; Zhang, T., et al. Lovastatin Inhibits Toll-Like Receptor 4 Signaling in Microglia by Targeting Its Co-Receptor Myeloid Differentiation Protein 2 and Attenuates Neuropathic Pain. Brain Behav. Immun. 2019, 82, 432–444. doi:10.1016/j.bbi.2019.09.013.
   PubMed Web of Science ®Google Scholar
• Agboyibor, C.; Kong, W. B.; Chen, D., Zhang, A.-M., Niu, S.-Q.; et al. Monascus Pigments Production, Composition, Bioactivity and Its Application: A Review. Biocatal Agric. Biotechnol. 2018, 16, 433–447. doi:10.1016/j.bcab.2018.09.012.
   Web of Science ®Google Scholar
• Feng, D.; Sun, J. G., and Sun, R. B., et al. Isoflavones and Phytosterols Contained in Xuezhikang Capsules Modulate Cholesterol Homeostasis in High-Fat Diet Mice. Acta Pharmacol. Sin. 2015, 36(12), 1462–1472. doi:10.1038/aps.2015.98.
   PubMed Web of Science ®Google Scholar
• Yang, H.; Pan, R.; Wang, J., Zheng, L., Li, Z., Guo, Q., Wang, C.; et al. Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet. Front Pharmacol. 2020, 11, 599760. doi:10.3389/fphar.2020.599760.
   PubMed Web of Science ®Google Scholar
• Sungthong, B.; Yoothaekool, C.; Promphamorn, S., and Phimarn, W.; et al. Efficacy of Red Yeast Rice Extract on Myocardial Infarction Patients with Borderline Hypercholesterolemia: A Meta-Analysis of Randomized Controlled Trials. Sci. Rep. 2020, 10(1), 2769. doi:10.1038/s41598-020-59796-5.
   PubMedGoogle Scholar
• Hachem, R.; Assemat, G.; Balayssac, S., Martins-Froment, N., Gilard, V., Martino, R., Malet-Martino, M. Comparative Chemical Profiling and Monacolins Quantification in Red Yeast Rice Dietary Supplements by (1) H-NMR and UHPLC-DAD-MS. Molecules. 2020, 25(2), 317. doi:10.3390/molecules25020317.
   PubMed Web of Science ®Google Scholar
• Shang, Q.; Liu, Z.; Chen, K., Xu, H., Liu, J.; et al. A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia. Evid. Based Complement. Alternat. Med. 2012, 2012, 636547. doi:10.1155/2012/636547.
   PubMed Web of Science ®Google Scholar
• Mach, F.; Baigent, C., and Catapano, A. L., et al. 2019 ESC/EAS Guidelines for Themanagement of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. Eur. Heart J. 2020, 41(1), 111–188. doi:10.1093/eurheartj/ehz455.
   PubMed Web of Science ®Google Scholar
• Wu, H. C.; Cheng, M. J.; Wu, M. D., Chen, J.-J., Chen, Y.-L., Chang, H.-S., and Chen, K.-P.; et al. Secondary Metabolites from the Fermented Rice of the Fungus Monascus Purpureus and Their Bioactivities. Nat. Prod. Res. 2019, 33(24), 3541–3550. doi:10.1080/14786419.2018.1488698.
   PubMed Web of Science ®Google Scholar
• Zuo, L. S.; Tang, X. Y., and Xiong, F., et al. Isoflavone Biomarkers are Inversely Associated with Atherosclerosis Progression in Adults: A Prospective Study. Am. J. Clin. Nutr. 2021, 114(1), 203–213. doi:10.1093/ajcn/nqab008.
   PubMed Web of Science ®Google Scholar
• Xiong, Z.; Cao, X.; Wen, Q., et al. An Overview of the Bioactivity of Monacolin K/lovastatin. Food Chem. Toxicol. 2019, 131(1), 110585. Doi:10.1016/j.fct.2019.110585.
   PubMedGoogle Scholar
• Pérez-Jiménez, F.; Pascual, V., and Meco, J. F., et al. Document of Recommendations of the SEA 2018. Lifestyle in Cardiovascular Prevention. Clin. Investig. Arterioscler. 2018, 30(6), 280–310. doi:10.1016/j.arteri.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Liang, J. X.; Zhang, Q. Q.; Huang, Y. F., Pang, H.-Q., Liu, X.-G., Gao, W., Li, P., Yang, H.; et al. Comprehensive Chemical Profiling of Monascus-Fermented Rice Product and Screening of Lipid-Lowering Compounds Other Than Monacolins. J. Ethnopharmacol. 2019, 238, 111879. doi:10.1016/j.jep.2019.111879.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F. G.; Colletti, A., and Bajraktari, G., et al. Lipid-Lowering Nutraceuticals in Clinical Practice: Position Paper from an International Lipid Expert Panel. Nutr. Rev. 2017, 75(9), 731–767. doi:10.5114/aoms.2017.69326.
   PubMed Web of Science ®Google Scholar
• Leone, G.; Consumi, M., and Pepi, S., et al. New Formulations to Enhance Lovastatin Release from Red Yeast Rice (RYR). J. Drug Deliv. 2016, 36, 110–119. doi:10.1016/j.jddst.2016.10.001.
   Web of Science ®Google Scholar
• Cicero, A. F. G.; Fogacci, F.; Zambon, A. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. J. Am. Coll. Cardiol. 2021, 77(5), 620–628. doi:10.1016/j.jacc.2020.11.056.
   PubMed Web of Science ®Google Scholar
• Endo, A. Monacolin K, a New Hypocholesterolemic Agent That Specifically Inhibits 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase. J. Antibiot. (Tokyo). 1980, 33(3), 334–336. doi:10.7164/antibiotics.33.334.
   PubMed Web of Science ®Google Scholar
• Banach, M.; Patti, A. M., and Giglio, R. V., et al. The Role of Nutraceuticals in Statin Intolerant Patients. J. Am. Coll. Cardiol. 2018, 72(1), 96–118. doi:10.1016/j.jacc.2018.04.040.
   PubMed Web of Science ®Google Scholar
• Fogacci, F.; Banach, M.; Mikhailidis, D. P., et al. Safety of Red Yeast Rice Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmacol. Res. 2019, 143, 1–16. doi:10.1016/j.phrs.2019.02.028.
   PubMed Web of Science ®Google Scholar
• Dufossé, L.; Galaup, P.; Yaron, A., Arad, S. M., Blanc, P., Chidambara Murthy, K. N., and Ravishankar, G. A.; et al. Microorganisms and Microalgae as Sources of Pigments for Food Use: A Scientific Oddity or an Industrial Reality? Trends Food Sci. Technol. 2005, 16(9), 389–406. doi:10.1016/j.tifs.2005.02.006.
   Web of Science ®Google Scholar
• Patakova, P. Monascus Secondary Metabolites: Production and Biological Activity. J. Ind. Microbiol. Biotechnol. 2013, 40(2), 169–181. doi:10.1007/s10295-012-1216-8.
   PubMed Web of Science ®Google Scholar
• Chen, W.; Chen, R., and Liu, Q., et al. Orange, Red, Yellow: Biosynthesis of Azaphilone Pigments in Monascus Fungi. Chem. Sci. 2017, 8(7), 4917–4925. doi:10.1039/c7sc00475c.
   PubMed Web of Science ®Google Scholar
• Kim, D.; Ku, S. Beneficial Effects of Monascus Sp. KCCM 10093 Pigments and Derivatives: A Mini Review. Molecules. 2018, 23(1), 98. doi:10.3390/molecules23010098.
   PubMed Web of Science ®Google Scholar
• Zhou, W.; Guo, R., and Guo, W., et al. Monascus Yellow, Red and Orange Pigments from Red Yeast Rice Ameliorate Lipid Metabolic Disorders and Gut Microbiota Dysbiosis in Wistar Rats Fed on a High-Fat Diet. Food Funct. 2019, 10(2), 1073–1084. doi:10.1039/c8fo02192a.
   PubMed Web of Science ®Google Scholar
• Jou, P. C.; Ho, B. Y.; Hsu, Y. W., and Pan, T.-M.; et al. The Effect of Monascus Secondary Polyketide Metabolites, Monascin and Ankaflavin, on Adipogenesis and Lipolysis Activity in 3T3-L1. J. Agric. Food Chem. 2010, 58(24), 12703–12709. doi:10.1021/jf103121c.
   PubMed Web of Science ®Google Scholar
• Lee, C. L.; Wen, J. Y., and Hsu, Y. W., et al. Monascus-Fermented Yellow Pigments Monascin and Ankaflavin Showed Antiobesity Effect via the Suppression of Differentiation and Lipogenesis in Obese Rats Fed a High-Fat Diet. J. Agric. Food Chem. 2013, 61(7), 1493–1500. doi:10.1021/jf304015z.
   PubMed Web of Science ®Google Scholar
• Sampson, U. K.; Linton, M. F.; Fazio, S. Are Statins Diabetogenic? Curr. Opin. Cardiol. 2011, 26(4), 342–347. doi:10.1097/HCO.0b013e3283470359.
   PubMed Web of Science ®Google Scholar
• Katsiki, N.; Rizzo, M.; Mikhailidis, D. P., and Mantzoros, C. S.; et al. New-Onset Diabetes and Statins: Throw the Bath Water Out, but, Please, Keep the Baby! Metabolism. 2015, 64(4), 471–475. doi:10.1016/j.metabol.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Yandrapalli, S.; Malik, A.; Guber, K., Rochlani, Y., Pemmasani, G., Jasti, M., and Aronow, W. S.; et al. Statins and the Potential for Higher Diabetes Mellitus Risk. Expert Rev. Clin. Pharmacol. 2019, 12(9), 825–830. doi:10.1080/17512433.2019.1659133.
   PubMed Web of Science ®Google Scholar
• Meinicke, R. M.; Vendruscolo, F., and Moritz, D. E., et al. Potential Use of Glycerol as Substrate for the Production of Red Pigments by Monascus Ruber in Submerged Fermentation. Biocatal. Agric. Biotechnol. 2012, 1(3), 238–242. doi:10.1016/j.bcab.2012.03.001.
   Google Scholar
• Vendruscolo, F.; Rossi, M. J., and Schmidell, W., et al. Determination of Oxygen Solubility in Liquid Media. ISRN Chem. Eng. 2012, 2012(3). doi:10.5402/2012/601458.
   Google Scholar
• Vendruscolo, F.; Pitol, L. O.; Carciofi, B., Moritz, D. E., Laurindo, J. B., Schmidell, W., and Ninow, J. L.; et al. Construction and Application a Vane System in a Rotational Rheometer for Determination of the Rheological Properties of Monascus Ruber CCT 3802. Biorheology. 2010, 24(1), 29–35. doi:10.1007/s12573-010-0019-7.
   Google Scholar
• Liu, H. Q.; Huang, Z. F.; Yang, S. Z., Tian, X.-F., and Wu, Z.-Q.; et al. Inducing Red Pigment and Inhibiting Citrinin Production by Adding Lanthanum(iii) Ion in Monascus Purpureus Fermentation. Appl. Microbiol. Biotechnol. 2021, 105(5), 1905–1912. doi:10.1007/s00253-021-11162-9.
   PubMed Web of Science ®Google Scholar
• Wong, H.; Koehler, P. E. Production and Isolation of an Antibiotic from Monascus Purpureus and Its Relationship to Pigment Production. J. Food Sci. 2010, 46(2), 589–592. doi:10.1111/j.1365-2621.1981.tb04917.x.
   Google Scholar
• Xu, W. Study on the Liquid Fermentation to Produce Monascus Pigment with Corn Starch and Antibacteria. Adv. Mater. Res. 2011, 183, 1336–1340. doi:10.4028/www.scientific.net/AMR.183-185.1336.
   Google Scholar
• Sun, J.-M.; Kim, S.-J., and Kim, G.-W., et al. Inhibition of Hepatitis C Virus Replication by Monascus Pigment Derivatives That Interfere with Viral RNA Polymerase Activity and the Mevalonate Biosynthesis Pathway. J. Antimicrob. Chemother. 2012, 67(1), 49–58. doi:10.1093/jac/dkr432.
   PubMed Web of Science ®Google Scholar
• Huang, Y. P.; Li, P.; Du, T., Du, X.-J., and Wang, S.; et al. Protective Effect and Mechanism of Monascus -Fermented Red Yeast Rice Against Colitis Caused by Salmonella Enterica Serotype Typhimurium ATCC 14028. Food Funct. 2020, 11(7), 6363–6375. doi:10.1039/d0fo01017k.
   PubMed Web of Science ®Google Scholar
• Shi, Y. X., and Chen, W. S. Monascin Ameliorate Inflammation in the Lipopolysaccharide-Induced BV-2 Microglial Cells via Suppressing the NF-κB/p65 Pathway. Iran J. Basic Med. Sci. 2020, 23(4), 461–468. doi:10.22038/ijbms.2020.41045.9702.
   PubMed Web of Science ®Google Scholar
• Tung, Y. C.; Chou, R. F.; Nagabhushanam, K., Ho, C.-T., and Pan, M.-H.; et al. 3′-Hydroxydaidzein Improves Obesity Through the Induced Browning of Beige Adipose and Modulation of Gut Microbiota in Mice with Obesity Induced by a High-Fat Diet. J. Agric. Food Chem. 2020, 68(49), 14513–14522. doi:10.1021/acs.jafc.0c06138.
   PubMed Web of Science ®Google Scholar
• Cardullo, N.; Muccilli, V.; Pulvirenti, L., and Tringali, C.; et al. Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors. J J. Nat. Prod. 2021, 84(3), 654–665. doi:10.1021/acs.jnatprod.0c01387.
   PubMed Web of Science ®Google Scholar
• Kim, S. K.; Ko, Y. H.; Lee, Y., Lee, S.-Y., and Jang, C.-G.; et al. Antineuroinflammatory Effects of 7,3’,4’-Trihydroxyisoflavone in Lipopolysaccharide-Stimulated BV2 Microglial Cells Through MAPK and NF-κB Signaling Suppression. Biomol. Ther. 2021, 29(2), 127–134. doi:10.4062/biomolther.2020.093.
   PubMed Web of Science ®Google Scholar
• Laddha, A. P.; Kulkarni, Y. A. Daidzein Ameliorates Diabetic Retinopathy in Experimental Animals. Life Sci. 2021, 265, 118779. doi:10.1016/j.lfs.2020.118779.
   PubMed Web of Science ®Google Scholar
• Kuryłowicz, A. The Role of Isoflavones in Type 2 Diabetes Prevention and Treatment-A Narrative Review. Int. J. Mol. Sci. 2020, 22(1), 218. doi:10.3390/ijms22010218.
   PubMed Web of Science ®Google Scholar
• Bhatt, P. C.; Pathak, S., and Kumar, V., et al. Attenuation of Neurobehavioral and Neurochemical Abnormalities in Animal Model of Cognitive Deficits of Alzheimer’s Disease by Fermented Soybean Nanonutraceutical. Inflammopharmacology. 2018, 26(1), 105–118. doi:10.1007/s10787-017-0381-9.
   PubMed Web of Science ®Google Scholar
• Kim, S. H.; Heo, J. H.; Kim, Y. S., Kang, S. S., Choi, J. S., and Lee, S.-M.; et al. Protective Effect of Daidzin Against D -Galactosamine and Lipopolysaccharide-Induced Hepatic Failure in Mice. Phytother. Res. 2009, 23(5), 701–706. doi:10.1002/ptr.2710.
   PubMed Web of Science ®Google Scholar
• Glisic, M.; Kastrati, N., and Gonzalez-Jaramillo, V., et al. Associations Between Phytoestrogens, Glucose Homeostasis, and Risk of Diabetes in Women: A Systematic Review and Meta-Analysis. Adv Nutr. 2018, 9(6), 726–740. doi:10.1093/advances/nmy048.
   PubMed Web of Science ®Google Scholar
• Meezan, E.; Meezan, E. M.; Jones, K., Moore, R., Barnes, S., and Prasain, J. K.; et al. Contrasting Effects of Puerarin and Daidzin on Glucose Homeostasis in Mice. J. Agric. Food Chem. 2005, 53(22), 8760–8767. doi:10.1021/jf058105e.
   PubMed Web of Science ®Google Scholar
• Wang, W.; Yang, R., and Zhang, M., et al. Glycitin Suppresses Cartilage Destruction of Osteoarthritis in Mice. Inflammation. 2020, 43(4), 1312–1322. doi:10.1007/s10753-020-01210-3.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Chen, J.; Chai, W., Ni, M., Sun, X., and Tian, D.; et al. Glycitin Regulates Osteoblasts Through TGF-β or AKT Signaling Pathways in Bone Marrow Stem Cells. Exp. Ther. Med. 2016, 12(5), 3063–3067. doi:10.3892/etm.2016.3696.
   PubMed Web of Science ®Google Scholar
• Zang, Y.; Igarashi, K.; Yu, C. Anti-Obese and Anti-Diabetic Effects of a Mixture of Daidzin and Glycitin on C57BL/6J Mice Fed with a High-Fat Diet. Biosci. Biotechnol., Biochem. 2015, 79(1), 117–123. doi:10.1080/09168451.2014.955453.
   PubMed Web of Science ®Google Scholar
• Zhong, H.; Liu, H.; Jiang, Z. Genistein Ameliorates Fat Accumulation Through AMPK Activation in Fatty Acid-Induced BRL Cells. J. Food Sci. 2017, 82(11), 2719–2725. doi:10.1111/1750-3841.13856.
   PubMed Web of Science ®Google Scholar
• Seidemann, L.; Krüger, A.; Kegel-Hübner, V., Seehofer, D., and Damm, G.; et al. Influence of Genistein on Hepatic Lipid Metabolism in an in vitro Model of Hepatic Steatosis. Molecules. 2021, 26(4), 1156. doi:10.3390/molecules26041156.
   PubMed Web of Science ®Google Scholar
• Liu, H.; Zhong, H.; Yin, Y., Jiang, Z.; et al. Genistein Has Beneficial Effects on Hepatic Steatosis in High Fat-High Sucrose Diet-Treated Rats. Biomed. Pharmacother. 2017, 91, 964–969. doi:10.1016/j.biopha.2017.04.130.
   PubMed Web of Science ®Google Scholar
• Yi, X. Y.; Wang, Z. H.; Wang, Y. Genistein for Glycolipid Metabolism in Postmenopausal Women: A Meta-Analysis. Climacteric. 2021, 24(3), 267–274. doi:10.1080/13697137.2020.1859473.
   PubMed Web of Science ®Google Scholar
• Makena, W.; Hambolu, J. O.; Timbuak, J. A., Umana, U. E., Iliya, A. I., and Dibal, N. I.; et al. Mormodica Charantia L. Fruit and Genistein Ameliorates Type 2 Diabetes in Rats by Preventing Lipid Accumulation, Insulin Resistance and Enhancing Beta Cell Function. J. Diabetes Metab. Disord. 2020, 19(2), 1303–1310. doi:10.1007/s40200-020-00648-4.
   PubMed Web of Science ®Google Scholar
• Zhou, L.; Xiao, X.; Zhang, Q., Zheng, J., Deng, M.; et al. Maternal Genistein Intake Mitigates the Deleterious Effects of High-Fat Diet on Glucose and Lipid Metabolism and Modulates Gut Microbiota in Adult Life of Male Mice. Front. Physiol. 2019, 10, 985. doi:10.3389/fphys.2019.00985.
   PubMed Web of Science ®Google Scholar
• Zhou, L.; Xiao, X.; Zhang, Q., et al. Dietary Genistein Could Modulate Hypothalamic Circadian Entrainment, Reduce Body Weight, and Improve Glucose and Lipid Metabolism in Female Mice. Int. J. Endocrinol. 2019, 2019, 2163838. doi:10.1155/2019/2163838.
   PubMed Web of Science ®Google Scholar
• Shen, H. H.; Huang, S. Y.; Kung, C. W., et al. Genistein Ameliorated Obesity Accompanied with Adipose Tissue Browning and Attenuation of Hepatic Lipogenesis in Ovariectomized Rats with High-Fat Diet. J. Nutr. Biochem. 2019, 67, 111–122. doi:10.1016/j.jnutbio.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Yang, H.; Lee, S. H., and Ji, H., et al. Orobol, an Enzyme-Convertible Product of Genistein, Exerts Anti-Obesity Effects by Targeting Casein Kinase 1 Epsilon. Sci. Rep. 2019, 9(1), 8942. doi:10.1038/s41598-019-43950-9.
   PubMedGoogle Scholar
• Choi, Y. R.; Shim, J.; Kim, M. J. Genistin: A Novel Potent Anti-Adipogenic and Anti-Lipogenic Agent. Molecules. 2020, 25(9), 2042. doi:10.3390/molecules25092042.
   PubMed Web of Science ®Google Scholar
• Islam, A.; Islam, M. S.; Uddin, M. N., Hasan, M. M. I., and Akanda, M. R.; et al. The Potential Health Benefits of the Isoflavone Glycoside Genistin. Arch. Pharm. Res. 2020, 43(4), 395–408. doi:10.1007/s12272-020-01233-2.
   PubMed Web of Science ®Google Scholar
• Nguyen, C. T.; Pham, N. M.; Do, V. V., Binns, C. W., Hoang, V. M., Dang, D. A., and Lee, A. H.; et al. Soyfood and Isoflavone Intake and Risk of Type 2 Diabetes in Vietnamese Adults. Eur. J. Clin. Nutr. 2017, 71(10), 1186–1192. doi:10.1038/ejcn.2017.76.
   PubMed Web of Science ®Google Scholar
• Pyo, Y. H.; Seong, K. S. Hypolipidemic Effects of Monascus-Fermented Soybean Extracts in Rats Fed a High-Fat and -Cholesterol Diet. J. Agric. Food Chem. 2009, 57(18), 8617–8622. doi:10.1021/jf901878c.
   PubMed Web of Science ®Google Scholar
• Gu, Y.; Chen, X.; Fu, S., Liu, W., Wang, Q., Liu, K.-J., Shen, J.; et al. Astragali Radix Isoflavones Synergistically Alleviate Cerebral Ischemia and Reperfusion Injury via Activating Estrogen Receptor-PI3K-Akt Signaling Pathway. Front Pharmacol. 2021, 12, 533028. doi:10.3389/fphar.2021.533028.
   PubMed Web of Science ®Google Scholar
• Gachumi, G.; Poudel, A.; Wasan, K. M., and El-Aneed, A.; et al. Analytical Strategies to Analyze the Oxidation Products of Phytosterols, and Formulation-Based Approaches to Reduce Their Generation. Pharmaceutics. 2021, 13(2), 268. doi:10.3390/pharmaceutics13020268.
   PubMed Web of Science ®Google Scholar
• Zhu, B.; Qi, F.; Wu, J., Yin, G., Hua, J., Zhang, Q., Qin, L.; et al. Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine. Front Pharmacol. 2019, 10, 1449. doi:10.3389/fphar.2019.01449.
   PubMed Web of Science ®Google Scholar
• Hu, J.; Wang, J., and Gan, Q. X., et al. Impact of Red Yeast Rice on Metabolic Diseases: A Review of Possible Mechanisms of Action. J. Agric. Food Chem. 2020, 68(39), 10441–10455. doi:10.1021/acs.jafc.0c01893.
   PubMed Web of Science ®Google Scholar
• Musa-Veloso, K.; Poon, T. H.; Elliot, J. A., and Chung, C.; et al. A Comparison of the LDL-Cholesterol Lowering Efficacy of Plant Stanols and Plant Sterols Over a Continuous Dose Range: Results of a Meta-Analysis of Randomized, Placebo-Controlled Trials. Prostaglandins Leukot. Essent. Fatty Acids. 2011, 85(1), 9–28. doi:10.1016/j.plefa.2011.02.001.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F. G.; D’-Addato, S.; Borghi, C. A. Randomized Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO (®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study). Nutrients. 2020, 12(10), 3127. doi:10.3390/nu12103127.
   PubMed Web of Science ®Google Scholar
• Domenech, M.; Casas, R.; Ruiz-León, A. M., Sobrino, J., Ros, E., and Estruch, R.; et al. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol®) on the Lipid Profile and Inflammatory Biomarkers: A Randomized Control Trial. Nutrients. 2019, 11(5), 949. doi:10.3390/nu11050949.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F. G.; Fogacci, F.; Rosticci, M.; Parini, A.; Giovannini, M.; Veronesi, M.; D’-Addato, S.; Borghi, C., et al. Effect of a Short-Term Dietary Supplementation with Phytosterols, Red Yeast Rice or Both on Lipid Pattern in Moderately Hypercholesterolemic Subjects: A Three-Arm, Double-Blind, Randomized Clinical Trial. Nutr. Metab. 2017, 14, 61. doi:10.1186/s12986-017-0214-2.
   Google Scholar
• Malinowski, J. M.; Gehret, M. M. Phytosterols for Dyslipidemia. Am. J. Health Syst. Pharm. 2010, 67(14), 1165–1173. doi:10.2146/ajhp090427.
   PubMed Web of Science ®Google Scholar
• Bruning, T.; Al-Khaled, M. Do Statins Reduce the Mortality Rate in Stroke Patients Treated with Systemic Thrombolysis in a 5-Year. Neural. Regen. Res. 2021, 16(9), 1807–1812. doi:10.4103/1673-5374.306088.
   PubMed Web of Science ®Google Scholar
• Yu, Q.; Chen, Y.; Xu, C. B. Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link. Front Pharmacol. 2017, 8, 372. doi:10.3389/fphar.2017.00372.
   PubMed Web of Science ®Google Scholar
• Brault, M.; Ray, J.; Gomez, Y. H., Mantzoros, C. S., and Daskalopoulou, S. S.; et al. Statin Treatment and New-Onset Diabetes: A Review of Proposed Mechanisms. Metabolism. 2014, 63(6), 735–745. doi:10.1016/j.metabol.2014.02.014.
   PubMed Web of Science ®Google Scholar
• Sattar, N.; Preiss, D., and Murray, H. M., et al. Statins and Risk of Incident Diabetes: A Collaborative Meta-Analysis of Randomised Statin Trials. Lancet. 2010, 375(9716), 735–742. doi:10.1016/S0140-6736(09)61965-6.
   PubMed Web of Science ®Google Scholar
• Mansi, I. A.; Frei, C. R.; Halm, E. A., and Mortensen, E. M.; et al. Association of Statins with Diabetes Mellitus and Diabetic Complications: Role of Confounders During Follow-Up. J. Investig. Med. 2017, 65(1), 32–42. doi:10.1136/jim-2016-000218.
   PubMed Web of Science ®Google Scholar
• Ramu, R.; Shirahatti, P. S.; Nayakavadi, S., R, V., Zameer, F., Dhananjaya, B. L., and Prasad MN, N.; et al. The Effect of a Plant Extract Enriched in Stigmasterol and β-Sitosterol on Glycaemic Status and Glucose Metabolism in Alloxan-Induced Diabetic Rats. Food Funct. 2016, 7(9), 3999–4011. doi:10.1039/c6fo00343e.
   PubMed Web of Science ®Google Scholar
• Ponnulakshmi, R.; Shyamaladevi, B.; Vijayalakshmi, P., and Selvaraj, J.; et al. In silico and in vivo Analysis to Identify the Antidiabetic Activity of Beta Sitosterol in Adipose Tissue of High Fat Diet and Sucrose Induced Type-2 Diabetic Experimental Rats. Toxicol. Mech. Methods. 2019, 29(4), 276–790. doi:10.1080/15376516.2018.1545815.
   PubMed Web of Science ®Google Scholar
• Xiong, M.; Huang, Y., and Liu, Y., et al. Antidiabetic Activity of Ergosterol from Pleurotus Ostreatus in KK-A Y Mice with Spontaneous Type 2 Diabetes Mellitus. Mol. Nutr. Food Res. 2018, 62(3), 1700444. doi:10.1002/mnfr.201700444.
   Web of Science ®Google Scholar
• Gao, F.; Wang, G.; Wang, L., and Guo, N.; et al. Phytosterol Nutritional Supplement Improves Pregnancy and Neonatal Complications of Gestational Diabetes Mellitus in a Double-Blind and Placebo-Controlled Clinical Study. Food Funct. 2017, 8(1), 424–428. doi:10.1039/c6fo01777k.
   PubMed Web of Science ®Google Scholar
• Xie, W.; Zhao, Y.; Du, L. Emerging Approaches of Traditional Chinese Medicine Formulas for the Treatment of Hyperlipidemia. J. Ethnopharmacol. 2012, 140(2), 345–367. doi:10.1016/j.jep.2012.01.027.
   PubMed Web of Science ®Google Scholar
• Gerards, M. C.; Terlou, R. J.; Yu, H., Koks, C. H. W., Gerdes, V. E. A.; et al. Traditional Chinese Lipid-Lowering Agent Red Yeast Rice Results in Significant LDL Reduction but Safety is Uncertain – A Systematic Review and 880 Meta-Analysis. Atherosclerosis. 2015, 240(2), 415–423. doi:10.1016/j.atherosclerosis.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Landi, F.; Martone, A. M.; Salini, S., et al. Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial. Biomed Res. Int. 2019, 2019, 1970878. doi:10.1155/2019/1970878.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F. G.; Kennedy, C.; Knežević, T.; Bove, M.; Georges, C. M. G.; Šatrauskienė, A.; Toth, P. P.; Fogacci, F., et al. Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and MetaAnalysis of Randomized Controlled Clinical Trials. Nutrients. 2021, 13(2), 638. doi:10.3390/nu13020638.
   PubMedGoogle Scholar
• Ruscica, M.; Pavanello, C., and Gandini, S., et al. Nutraceutical Approach for the Management of Cardiovascular Risk - a Combination Containing the Probiotic Bifidobacterium Longum BB536 and Red Yeast Rice Extract: Results from a Randomized, Double-Blind, Placebo-Controlled Study. Nutr. J. 2019, 18(1), 13. doi:10.1186/s12937-019-0438-2.
   PubMed Web of Science ®Google Scholar
• Hermans, N.; Van der Auwera, A.; Breynaert, A., Verlaet, A., De Bruyne, T., Van Gaal, L., Pieters, L., and Verhoeven, V.; et al. A Red Yeast Rice-Olive Extract Supplement Reduces Biomarkers of Oxidative Stress, OxLdl and Lp-PLA(2), in Subjects with Metabolic Syndrome: A Randomised, Double-Blind, Placebo-Controlled Trial. Trials. 2017, 18(1), 302. doi:10.1186/s13063-017-2058-5.
   PubMedGoogle Scholar
• Derosa, G.; Catena, G., and Raddino, R., et al. Effects on Oral Fat Load of a Nutraceutical Combination of Fermented Red Rice, Sterol Esters and Stanols, Curcumin, and Olive Polyphenols: A Randomized, Placebo Controlled Trial. Phytomedicine. 2018, 42, 75–82. doi:10.1016/j.phymed.2018.01.014.
   Google Scholar
• Spigoni, V.; Aldigeri, R., and Antonini, M., et al. Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study. Int. J. Mol. Sci. 2017, 18(7), 1498. doi:10.3390/ijms18071498.
   PubMed Web of Science ®Google Scholar
• D’-Addato, S.; Scandiani, L., and Mombelli, G. , et al. Effect of a Food Supplement Containing Berberine, Monacolin K, Hydroxytyrosol and Coenzyme Q(10) on Lipid Levels: A Randomized, Double-Blind, Placebo Controlled Study. Drug Des. Devel. Ther. 11, 1585–1592. doi:10.2147/DDDT.S128623.
   PubMed Web of Science ®Google Scholar
• Marazzi, G.; Campolongo, G.; Pelliccia, F., Quattrino, S., Vitale, C., Cacciotti, L., Massaro, R., Volterrani, M., and Rosano, G.; et al. Comparison of Low-Dose Statin versus Low-Dose Statin + armolipid Plus in High-Intensity Statin-Intolerant Patients with a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial). Am. J. Cardiol. 2017, 120(6), 893–897. doi:10.1016/j.amjcard.2017.06.015.
   PubMed Web of Science ®Google Scholar
• Mercurio, V.; Pucci, G., and Bosso, G., et al. A Nutraceutical Combination Reduces Left Ventricular Mass in Subjects with Metabolic Syndrome and Left Ventricular Hypertrophy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Clin. Nutr. 2020, 39(5), 1379–1384. doi:10.1016/j.clnu.2019.06.026.
   PubMed Web of Science ®Google Scholar
• Mazza, A.; Lenti, S.; Schiavon, L., Di Giacomo, E., Tomasi, M., Manunta, R., Torin, G., Townsend, D. M., Rubello, D.; et al. Effect of Monacolin K and COQ10 Supplementation in Hypertensive and 890 Hypercholesterolemic Subjects with Metabolic Syndrome. Biomed. Pharmacother. 2018, 105, 992–996. doi:10.1016/j.biopha.2018.06.076.
   PubMed Web of Science ®Google Scholar
• Cimaglia, P.; Vieceli Dalla Sega, F.; Vitali, F., et al. Effectiveness of a Novel Nutraceutical Compound Containing 885 Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects with Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study. Front. Physiol. 2019, 10, 217. doi:10.3389/fphys.2019.00217.
   PubMed Web of Science ®Google Scholar
• Mazza, A.; Schiavon, L.; Rigatelli, G., Torin, G., Montanaro, F., and Lenti, S.; et al. The Short-Term Supplementation of Monacolin K Improves the Lipid and Metabolic Patterns of Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk. Food Funct. 2018, 9(7), 3845–3852. doi:10.1039/c8fo00415c.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F.; Morbini, M.; Rosticci, M., D''Addato, S., Grandi, E., and Borghi, C.; et al. Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects. Ann. Nutr. Metab. 2016, 68(3), 213–219. doi:10.1159/000445359.
   PubMed Web of Science ®Google Scholar
• Heinz, T.; Schuchardt, J. P.; Möller, K., Hadji, P., and Hahn, A.; et al. Low Daily Dose of 3 Mg Monacolin K from RYR Reduces the Concentration of LDL-C in a Randomized, Placebo-Controlled Intervention. Nutr. Res. 2016, 36(10), 1162–1170. doi:10.1016/j.nutres.2016.07.005.
   PubMed Web of Science ®Google Scholar
• Kasliwal, R. R.; Bansal, M., and Gupta, R., et al. ESSENS Dyslipidemia: A Placebo-Controlled, Randomized Study of a Nutritional Supplement Containing Red Yeast Rice in Subjects with Newly Diagnosed Dyslipidemia. Nutrition. 2016, 32(7–8), 767–776. doi:10.1016/j.nut.2016.01.012.
   PubMed Web of Science ®Google Scholar
• Adorni, M. P.; Ferri, N.; Marchianò, S., Trimarco, V., Rozza, F., Izzo, R., Bernini, F., Zimetti, F.; et al. Effect of a Novel Nutraceutical Combination on Serum Lipoprotein Functional Profile and Circulating PCSK9. Ther Clin Risk ManagTher. 2017, 13, 1555–1562. doi:10.2147/TCRM.S144121.
   PubMed Web of Science ®Google Scholar
• Gou, S. H.; Liu, B. J.; Han, X.F.; Wang, L.; Zhong, C.; Liang, S.; Liu, H.; Qiang, Y., and Zhang, Y., et al. Anti-Atherosclerotic Effect of Fermentum Rubrum and Gynostemma Pentaphyllum Mixture in High-Fat Emulsion- and Vitamin D(3)-Induced Atherosclerotic Rats. J. Chin. Med. Assoc. 2018, 81(5), 398–408. doi:10.1016/j.jcma.2017.08.018.
   PubMed Web of Science ®Google Scholar
• Gou, S. H.; Huang, H. F.; Chen, X. Y., Liu, J., He, M., Ma, Y.-Y., Zhao, X.-N., Zhang, Y., and Ni, J.-M.; et al. Lipid-Lowering, Hepatoprotective, and Atheroprotective Effects of the Mixture Hong-Qu and Gypenosides in Hyperlipidemia with NAFLD Rats. J. Chin. Med. Assoc. 2016, 79(3), 111–121. doi:10.1016/j.jcma.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Dong, Y.; Cheng, H.; Liu, Y., Xue, M., and Liang, H.; et al. Red Yeast Rice Ameliorates High-Fat Diet-Induced Atherosclerosis in Apoe −/− Mice in Association with Improved Inflammation and Altered Gut Microbiota Composition. Food Funct. 2019, 10(7), 3880–3889. doi:10.1039/c9fo00583h.
   PubMed Web of Science ®Google Scholar
• Chen, T. L.; Lin, C. S.; Lin, J. A., Yeh, C.-C., Sung, L.-C., Chang, Y.-C., Shih, C.-C., Liao, C.-C.; et al. Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database. Diabetes Metab. Syndr. Obes. 2020, 13, 89–98. doi:10.2147/DMSO.S223833.
   PubMed Web of Science ®Google Scholar
• Wu, B.; Huang, J. F.; He, B. J., Huang, C.-W., Lu, J.-H.; et al. Promotion of Bone Formation by Red Yeast Rice in Experimental Animals: A Systematic Review and Meta-Analysis. Biomed Res. Int. 2020, 2020, 7231827. doi:10.1155/2020/7231827.
   PubMed Web of Science ®Google Scholar
• Banach, M.; Penson, P. E. What Have We Learned About Lipids and Cardiovascular Risk from PCSK9 Inhibitor Outcome Trials: ODYSSEY and FOURIER? Cardiovasc. Res. 2019, 115(3), e26–e31. doi:10.1093/cvr/cvy301.
   PubMed Web of Science ®Google Scholar
• Mazzanti, G.; Moro, P. A.; Raschi, E.; Da Cas, R., and Menniti‐ippolito, F., et al. Adverse Reactions to Dietary Supplements Containing Red Yeast Rice: Assessment of Cases from the Italian Surveillance System. Br.J. Clin. Pharmacol. 2017, 83(4), 894–908. doi:10.1111/bcp.13171.
   PubMed Web of Science ®Google Scholar
• Vrolijk, M. F.; van de Koppel, S.; van Hunsel, F. Red Yeast Rice (Monascus purpureus) Supplements: Case Series Assessment of Spontaneously Reported Cases to the Netherlands Pharmacovigilance Centre Lareb. Br.J. Clin. Pharmacol. 2021, 87(4), 2146–2151. doi:10.1111/bcp.14599.
   PubMed Web of Science ®Google Scholar
• Cicero, A.; Fogacci, F.; Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., and Rizzo, M.; et al. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-Optimal Lipid Levels? Curr. Atheroscler. Rep. 2021, 23(10), 57. doi:10.1007/s11883-021-00955-y.
   PubMed Web of Science ®Google Scholar
• Righetti, L.; Dall’-Asta, C.; Bruni, R. Risk Assessment of RYR Food Supplements: Perception Vs. Reality. Front Nutr. 2021, 8, 792529. doi:10.3389/fnut.2021.792529.
   PubMed Web of Science ®Google Scholar
• Younes, M.; Aggett, P., and Aguilar, F., et al. Scientific Opinion on the Safety of Monacolins in Red Yeast Rice. Efsa J. 2018, 16(8), e05368. doi:10.2903/j.efsa.2018.5368.
   PubMed Web of Science ®Google Scholar
• Venhuis, B. J.; van Hunsel, F., and van de Koppel, S. , et al. Pharmacologically Effective Red Yeast Rice Preparations Marketed as Dietary Supplements Illustrated by a Case Report. Drug Test Anal. 2016, 8(3–4), 315–318. doi:10.1002/dta.1929.
   PubMed Web of Science ®Google Scholar